Leaders in Fight Against Typhoid Express Hope in Light of New Vaccines

BANGKOK, THAILAND — November 5, 2013— The Coalition against Typhoid (CaT), an initiative of the Sabin Vaccine Institute, will convene scientists, researchers and biotech experts this week at the Vaccines for Enteric Diseases (VED) Conference to discuss how a highly anticipated conjugate typhoid vaccine could expedite global efforts to help prevent this disease. For the first time, children as young as six months of age can be protected against typhoid with a vaccine. Both adults and children will receive high levels of long lasting protection.

Michael Posner Joins Sabin Vaccine Institute’s Board of Trustees

WASHINGTON, DC – October 21, 2013 – The Sabin Vaccine Institute today announced the election to its Board of Trustees of Michael H. Posner, Professor of Business and Society at New York University’s Stern School of Business. For more than three decades, Mr. Posner has advanced the causes of inclusive global human rights, dignity, freedom and justice.

Dr. Albert B. Sabin is best known for developing the oral live virus polio vaccine, but his legacy extends far beyond this single groundbreaking medical advancement.

Dengue fever, also known as breakbone fever, is a leading cause of illness and death in the tropics and subtropics and is transmitted through a simple mosquito bite.

On September 13th, the WHO South-East Asia Regional Committee announced a new commitment to eliminate measles and control rubella by 2020.

Sabin is happy to announce the arrival of our 2012 Annual Report, featuring highlights from our three programs – Vaccine Advocacy and Education, The

At Sabin’s Second Sustainable Immunization Financing Colloquium, held in Dakar, Senegal on 5-6 August, 2013, we had the chance to get a few thoughts from Zangad Bayanselenge, Member of the Great State of Hural and Chair of the Standing Committee on Social Policy, Education, Culture and Scien

Pages

Subscribe to RSS - Vaccine Advocacy and Education